www.fdanews.com/articles/176947-zimmer-to-acquire-ldr-for-1-b
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/GreenDollarSign.gif?t=1433864063&width=430)
Zimmer to Acquire LDR for $1 B
June 7, 2016
Zimmer Biomet has entered a definitive agreement to acquire LDR for roughly $1 billion, the company announced Tuesday.
Under the agreement, which is expected to close during the third quarter of this year, Zimmer will gain all outstanding shares of LDR for $37 per share.
According to Zimmer, acquiring the spinal devicemaker will boost its “presence in the global spine market.” — Anisa Jibrell